[ad_1]
The company said it has started commercializing variant-adapted COVID vaccines for the coming season, and is also building on development efforts for other drug candidates.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...